Last updated: November 13, 2026
injective price prediction estimates for 2026-2030 depend on whether network use and new products can support INJ demand over time. As of November 13, 2026, INJ was trading at $8.07, far below its record high, while two published models show a wide range of possible 2030 outcomes.
Key Takeaways
- CoinGecko recorded INJ at $8.07 at 17:24 UTC on November 13, 2026.
- Injective reported $12.86 billion in onchain orderbook trading over the year to November 6, 2026, but DeFiLlama listed $17.49 million in chain TVL on November 13.
- Published 2030 model estimates differ substantially: TokenSonar’s bear case is $3.16 and its bull case is $64.96. These are model outputs, not assured outcomes or institutional targets.
Injective price prediction snapshot and market data
| Metric | INJ data |
|---|---|
| Price | $8.07 |
| Market capitalization | $806.55 million |
| 24-hour trading volume | $125.62 million |
| 24-hour range | $7.16-$8.26 |
| 24-hour change | +9.59% |
| Seven-day change | -2.18% |
| Circulating supply | 100 million INJ |
| Snapshot time | November 13, 2026, 17:24 UTC |
These figures are CoinGecko market data, and short-term percentage moves can change quickly. CoinGecko lists the all-time high at $52.62 on March 14, 2024, and the all-time low at $0.657401. The market data provided does not include the low’s date. The current price is about 85% below the peak, a reminder that long-term forecasts sit alongside substantial volatility.
INJ price history and key levels
INJ’s record high came in March 2024. At the November 13, 2026 snapshot, its price remained well below that level, despite a 9.07% gain over the preceding year and 6.37% over the past 30 days, according to CoinGecko. The 24-hour range of $7.16-$8.26 offers a dated short-term reference, not a dependable support or resistance signal.
The Crypto Fear & Greed Index registered 20, classified as Extreme Fear, on November 13, 2026. Sentiment can shift, and that reading alone does not establish where INJ will trade next.

Fundamental drivers and catalysts
Network activity is a potential driver, though activity does not automatically translate into token demand. Injective’s November 8 annual review reported $12.86 billion in onchain orderbook trading from November 8, 2025, to November 6, 2026. It also reported nearly $1.8 billion in real-world-asset perpetuals trading, with October 2026 the busiest month for that product.
DeFiLlama’s November 13 snapshot gives a more mixed picture: $17.49 million in DeFi total value locked, $15.85 million in stablecoins, $1.42 million in 24-hour DEX volume and $29.3 million in perpetuals volume. Whether those measures grow matters for a longer-term injective price prediction, particularly if the network can sustain activity beyond individual launches.
Injective’s Veyra mainnet proposal entered governance voting on November 12. The official upgrade tracker lists the release as “Soon” and a planned halt at block 193,145,000; crypto.news reported a November 24 target, subject to approval. Planned features include institutional real-world assets and cross-chain trading. Delivery and user uptake remain uncertain.
Another catalyst is the Canary Staked INJ ETF, ticker INJC, which began trading on Nasdaq on November 5, according to Injective. The project said the fund seeks to reflect INJ exposure plus staking rewards. Injective also reported 7,295,039 cumulative INJ burned since 2021 and annual issuance of 2.2%-4.4%; these project-reported tokenomics figures do not assure price appreciation.

Risks to the Injective price outlook
INJ remains exposed to broad crypto-market volatility, and holders can lose some or all of their funds. Trading and TVL figures do not prove durable demand for the token. Veyra depends on governance approval and successful implementation, while ETF access does not remove market, custody or regulatory risks.
Competition, changing regulations, technical faults, smart contract vulnerabilities and exchange disruption can also weigh on activity or access. Staking rewards and issuance can change; neither rewards nor token burns promise a particular return. The Extreme Fear reading is a dated sentiment measure, not a safety signal.
Injective price prediction scenarios for 2026-2030
The figures below are published model scenarios, not certain outcomes. The evidence provided contains forecasts for December 2026 and 2030, but not for 2027-2029, so those years are not assigned estimates here.
| Forecast | Horizon | Bear case | Base case | Bull case |
|---|---|---|---|---|
| Crypto.news | December 2026 | $8.10 | $9.53 | $11.44 |
| Crypto.news | 2030 | Not listed | $25.86 | $36.20 |
| TokenSonar | November 2030 | $3.16 | $14.32 | $64.96 |
Crypto.news’s model, updated November 9, gave the December 2026 scenarios shown above and a 2030 base case of $25.86 and bull case of $36.20. TokenSonar’s separate model, revised November 7, put its November 2030 base at $14.32, bear at $3.16 and bull at $64.96. The wide spread shows how sensitive model-based injective price prediction figures are to assumptions.

Methodology and assumptions
The table reports the cited models’ published estimates without filling gaps with interpolated values. Crypto.news describes its figures as estimates based on historical data and model assumptions, not institutional analyst targets. TokenSonar identifies its figures as its own model output. Both sets of estimates can change as conditions and assumptions change. They should be considered alongside market and execution risks. This injective price prediction is informational, not financial advice.
Frequently asked questions
What is the Injective price prediction for 2026?
Crypto.news’s model forecast $8.10-$11.44 for December 2026, with a $9.53 base case. It is a model estimate, not an assured price.
Could INJ reach $25 by 2030?
The cited 2030 base cases are $14.32 from TokenSonar and $25.86 from Crypto.news. These are separate model estimates and do not establish that INJ will reach $25.
What could influence INJ’s price?
Network trading activity, Veyra implementation, token issuance and burns, ETF access, broader crypto conditions and regulation may all matter. Their effects are uncertain.
Is Injective a low-risk investment?
No crypto asset is risk-free. INJ can be highly volatile, and technical, regulatory, exchange and market risks can result in losses, including a total loss.
Sources
- Upgrades | Injective Chain (chain.injective.network)
- Injective price and market data (CoinGecko)
- Injective Veyra upgrade heads to governance vote ahead of November 24 launch (crypto.news)
This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrencies are highly volatile; always do your own research before investing.

